ES443766A1 - Un procedimiento de preparacion de derivados del triptofa- no. - Google Patents

Un procedimiento de preparacion de derivados del triptofa- no.

Info

Publication number
ES443766A1
ES443766A1 ES443766A ES443766A ES443766A1 ES 443766 A1 ES443766 A1 ES 443766A1 ES 443766 A ES443766 A ES 443766A ES 443766 A ES443766 A ES 443766A ES 443766 A1 ES443766 A1 ES 443766A1
Authority
ES
Spain
Prior art keywords
nervous system
central nervous
increased effect
tryptophan derivatives
denotes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES443766A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cooperation Pharmaceutique Francaise SAS
Original Assignee
Cooperation Pharmaceutique Francaise SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cooperation Pharmaceutique Francaise SAS filed Critical Cooperation Pharmaceutique Francaise SAS
Publication of ES443766A1 publication Critical patent/ES443766A1/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/02Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements
    • C07D295/027Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements containing only one hetero ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/10Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D209/20Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals substituted additionally by nitrogen atoms, e.g. tryptophane
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F1/00Compounds containing elements of Groups 1 or 11 of the Periodic Table
    • C07F1/005Compounds containing elements of Groups 1 or 11 of the Periodic Table without C-Metal linkages
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F3/00Compounds containing elements of Groups 2 or 12 of the Periodic Table
    • C07F3/003Compounds containing elements of Groups 2 or 12 of the Periodic Table without C-Metal linkages

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Indole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ES443766A 1974-12-23 1975-12-22 Un procedimiento de preparacion de derivados del triptofa- no. Expired ES443766A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7442505A FR2295746A1 (fr) 1974-12-23 1974-12-23 Nouveaux derives du tryptophane a activite nerveuse centrale renforcee

Publications (1)

Publication Number Publication Date
ES443766A1 true ES443766A1 (es) 1977-04-16

Family

ID=9146520

Family Applications (1)

Application Number Title Priority Date Filing Date
ES443766A Expired ES443766A1 (es) 1974-12-23 1975-12-22 Un procedimiento de preparacion de derivados del triptofa- no.

Country Status (6)

Country Link
US (1) US4299838A (es)
BE (1) BE836954A (es)
DE (1) DE2557497C2 (es)
ES (1) ES443766A1 (es)
FR (1) FR2295746A1 (es)
GB (1) GB1529340A (es)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH04506967A (ja) * 1989-07-27 1992-12-03 ジー.ディー.サール アンド カンパニー 高血圧症治療用腎選択性生成物
US5939076A (en) * 1997-11-12 1999-08-17 Allocca Techical, Inc. Composition and method for treating or alleviating migraine headaches
WO1999052539A1 (en) 1998-04-10 1999-10-21 Mayo Foundation For Medical Education And Research Neo-tryptophan
US7087575B2 (en) * 2002-07-18 2006-08-08 Mayo Foundation For Medical Education And Research Treating the effect of nicotine
DK1549333T3 (da) 2002-09-20 2012-01-16 Univ Pennsylvania Compstatinanaloge med forbedret aktivitet
US7399324B2 (en) * 2004-01-29 2008-07-15 Camovision Of Georgia, Llc Active agent delivery device
CA2625206C (en) 2005-10-08 2021-12-07 Potentia Pharmaceuticals, Inc. Compstatin and analogs thereof for eye disorders
US8168584B2 (en) 2005-10-08 2012-05-01 Potentia Pharmaceuticals, Inc. Methods of treating age-related macular degeneration by compstatin and analogs thereof
CN106188239B (zh) 2005-11-28 2020-01-07 宾夕法尼亚州大学理事会 有效的坎普他汀类似物
WO2007100718A2 (en) * 2006-02-24 2007-09-07 Denise Barbut Neurotensin receptor agonists and opioid receptor agonists
WO2007114948A2 (en) * 2006-04-04 2007-10-11 The Brigham And Women's Hospital, Inc. Methods and compositions for inhibiting cell death
AU2008214359B2 (en) 2007-02-05 2014-01-16 Apellis Pharmaceuticals, Inc. Local complement inhibition for treatment of complement-mediated disorders
CN102458438A (zh) 2009-05-01 2012-05-16 宾夕法尼亚州大学理事会 具有肽骨架和c-末端修饰的经修饰补体抑素
CA2813049A1 (en) 2010-09-23 2012-03-29 The Trustees Of The University Of Pennsylvania Modified compstatin with improved stability and binding properties
CA2835627C (en) 2011-05-11 2023-01-10 Apellis Pharmaceuticals, Inc. Cell-reactive, long-acting, or targeted compstatin analogs and uses thereof
EP2723361B1 (en) 2011-06-22 2019-10-30 Apellis Pharmaceuticals, Inc. Methods of treating chronic disorders with complement inhibitors
CA2847862C (en) 2011-09-07 2021-01-12 The Trustees Of The University Of Pennsylvania Compstatin analogs with improved pharmacokinetic properties
EP3929206A1 (en) 2012-11-15 2021-12-29 Apellis Pharmaceuticals, Inc. Long-acting compstatin analogs and related compositions and methods
US10308687B2 (en) 2013-03-15 2019-06-04 Apellis Pharmaceuticals, Inc. Cell-penetrating compstatin analogs and uses thereof
WO2015142701A1 (en) 2014-03-17 2015-09-24 The Trustees Of The University Of Pennsylvania Compstatin analogs with improved potency and pharmacokinetic properties
CA3287719A1 (en) 2015-10-07 2026-03-02 Apellis Pharmaceuticals, Inc. Use of long-acting compstatin analog for treating a complement-mediated disorder
CN116059313A (zh) 2017-04-07 2023-05-05 阿佩利斯制药有限公司 给药方案以及相关组合物和方法
KR20240167712A (ko) 2017-12-15 2024-11-27 아펠리스 파마슈티컬스 인코포레이티드 투여 요법 및 관련 조성물 및 방법
WO2019195712A2 (en) 2018-04-06 2019-10-10 The Trustees Of The University Of Pennsylvania Compstatin analogs with increased solubility and improved pharmacokinetic properties

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2865928A (en) * 1956-08-03 1958-12-23 Du Pont Resolution of n-acyl-dl-tryptophans
GB873777A (en) * 1959-01-26 1961-07-26 Upjohn Co 5-hydroxy-ª--alkyltryptophans
BE791909A (fr) * 1971-11-24 1973-05-24 Beecham Group Ltd Compositions pharmaceutiques contenant du lithium et du tryptophane

Also Published As

Publication number Publication date
FR2295746B1 (es) 1978-08-18
US4299838A (en) 1981-11-10
DE2557497C2 (de) 1983-11-03
GB1529340A (en) 1978-10-18
BE836954A (fr) 1976-04-16
DE2557497A1 (de) 1976-06-24
FR2295746A1 (fr) 1976-07-23

Similar Documents

Publication Publication Date Title
ES468378A1 (es) Procedimiento de preparacion de un derivado de acetamina.
MY100740A (en) Spiro-substituted glutaramide diuretic agents.
ES8306767A1 (es) "metodo de preparar compuestos esteroidicos antiinflamatorios".
AU512448B2 (en) The use of cyclic carbonic acid esters as solvents for poly-(b-hydroxy butric acid
ES8801618A1 (es) Un procedimiento para preparar derivados de arilciclobutilalquilamina
KR790000113B1 (en) Method for preparation of dopamine derivatives
ES444948A1 (es) Un procedimiento para la separacion de impurezas contaminan-tes del acido clavulanico.
ES439927A1 (es) Procedimiento para la obtencion de 7-metoxi-6-tiatetracicli-nas.
ES458557A1 (es) Un procedimiento de preparacion de derivados de quinazolina.
ES450897A1 (es) Procedimiento para la preparacion de n-(r-tetrahidrofurfu- ril)-noroximorfona y n-(s-tetrahidrofurfuril)-noroximorfona.
GB1171670A (en) Derivatives of 4-Aryl-3-Hydroxybutyric Acid
GB1215498A (en) Succinic acid derivatives and their use in detergent compositions
SE7510785L (sv) Sett att framstella nya, kvevehaltiga, polycykliska foreningar
GB1385409A (en) Process for the resolution of d,l -phenylpropanolamine
ES463682A1 (es) Procedimiento de preparacion de nuevos derivados de la coen-zima b12.
ES427115A1 (es) Procedimiento de preparacion de nuevos derivados del acido acetico.
GB1495778A (en) Hexahydroazepines
GB1490290A (en) Preparation of penicillanic acid derivatives
GB894460A (en) Improvements in or relating to penicillins
ES454307A1 (es) Procedimiento para la preparacion de nuevos derivados de ci-clopentano.
GB1201977A (en) Penicilloic acid derivatives and a process for the manufacture thereof
GB1269832A (en) TRICYCLO(4.4.0.0<3.8>)DECAN-1-AMINE AND alpha-METHYLTRICYCLO(4.4.0.0<3.8>)DECAN-1-METHYLAMINE AND PROCESS FOR PREPARING SAME
GB1266889A (es)
JPS5278887A (en) Synthesis of n-(2-tetrahydrofuryl)-5-fluorouracil
GB1448295A (en) Thiosemicarbazones

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19980202